Ozempic vs Wegovy vs Mounjaro: Which Weight Loss Drug Actually Works Best in 2026?
Ozempic vs Wegovy vs Mounjaro 2026: Which works best? Mounjaro wins — 20-22% weight loss vs 15-17% for Wegovy. Side effects, cost, insurance, and who qualifies.
Three brand names dominate the 2026 weight loss conversation: Ozempic, Wegovy, and Mounjaro. Americans spent $14.8 billion on these drugs in 2025. But which one actually works best? Are they safe long-term? And who qualifies? qivsy breaks down the medical evidence.
What These Drugs Are
All three are GLP-1 receptor agonists — drugs that mimic a gut hormone (GLP-1) that regulates appetite and blood sugar. Originally developed for type 2 diabetes, their dramatic weight loss side effects transformed them into the most-discussed medications in America.
- Ozempic (semaglutide) — weekly injection. FDA-approved for type 2 diabetes. Often prescribed off-label for weight loss.
- Wegovy (semaglutide) — same drug as Ozempic, higher dose. FDA-approved specifically for weight loss in adults with BMI ≥30 or ≥27 with a weight-related condition.
- Mounjaro (tirzepatide) — weekly injection. Dual-action: targets both GLP-1 AND GIP receptors. FDA-approved for diabetes; weight loss version is Zepbound.
The Head-to-Head Clinical Data
| Drug | Avg weight loss | % reaching 15%+ loss | Monthly cost (without insurance) |
|---|---|---|---|
| Wegovy (semaglutide 2.4mg) | 15-17% of body weight | 51% | $1,349 |
| Mounjaro/Zepbound (tirzepatide 15mg) | 20-22% of body weight | 63% | $1,059 |
| Ozempic (semaglutide 1mg) | 9-12% of body weight | 31% | $936 |
Verdict: Mounjaro/Zepbound produces significantly more weight loss than Wegovy in clinical trials — 20-22% vs 15-17% body weight reduction on average.
Side Effects — What You Need to Know
Most common: nausea, vomiting, diarrhea, constipation (especially in the first 4-8 weeks). Serious but rare: pancreatitis, thyroid tumors (shown in animal studies — not confirmed in humans). New 2025 concern: a growing body of evidence linking these drugs to muscle mass loss alongside fat — particularly without exercise. 25-40% of the weight lost on GLP-1 drugs may be muscle, not fat.
Who Qualifies?
FDA criteria for Wegovy/Zepbound: BMI ≥30 OR BMI ≥27 with at least one weight-related condition (type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease).
The Insurance Problem
Most commercial insurance covers these drugs. Medicare does NOT cover GLP-1 drugs for weight loss (only for diabetes) — leaving 64 million Medicare beneficiaries without coverage. Out-of-pocket cost: up to $16,188/year for Wegovy. Manufacturer coupons available for some commercially-insured patients.
FAQ
Which is better, Ozempic or Wegovy? Wegovy at 2.4mg dose produces more weight loss than Ozempic at 1mg. Same drug, different dose and FDA indication.
Is Mounjaro better than Wegovy for weight loss? Yes — clinical trials show Mounjaro/Zepbound produces 20-22% body weight loss vs. 15-17% for Wegovy.
Does insurance cover Ozempic for weight loss? Coverage varies. Many insurers cover it for diabetes but not for weight loss specifically.
— Dana Cruz, qivsy Health & Society Reporter, Atlanta